NYSE:GSK

GSK (GSK) News Today

$34.71

+0.35 (+1.02%)

(As of 03:10 PM ET)

Compare

Today's Range: $34.37
▼
$34.73
50-Day Range: $33.60
▼
$38.32
52-Week Range: $28.47
▼
$44.75

Volume: 1.96 million shs
Average Volume: 3.29 million shs
Market Capitalization: $71.07 billion

P/E Ratio: 4.19
Dividend Yield: 3.92%
Price Target: N/A

Get GSK News Delivered to You Automatically

GSK Media Mentions By Week

GSK Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

GSK
News Sentiment
▼
0.56

0.51
▲
Average
Medical
News Sentiment

GSK News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

GSK Articles
This Week
▼
22

7
▲
GSK Articles
Average Week

Source

Source	Headline
	GSK employees to escalate strike action in June -union msn.com - June 8 at 11:03 AM
	GSK plc (NYSE:GSK) to Post Q4 2024 Earnings of $0.90 Per Share, Zacks Research Forecasts americanbankingnews.com - June 8 at 8:32 AM
	GSK plc (NYSE:GSK) Shares Sold by Atria Wealth Solutions Inc. marketbeat.com - June 8 at 5:58 AM
	GSK plc (NYSE:GSK) Given Average Rating of "Hold" by Brokerages americanbankingnews.com - June 8 at 3:54 AM
	GSK Receives Authorization for RSV Vaccine From European Commission marketwatch.com - June 7 at 7:36 PM
	EU gives final approval for GSK's RSV vaccine msn.com - June 7 at 7:36 PM
	GSK's Arexvy Gets the Green Light in Europe: First-Ever RSV Vaccine in Europe for Older Adults finance.yahoo.com - June 7 at 2:35 PM
	GSK wins EU approval for RSV vaccine Arexvy seekingalpha.com - June 7 at 9:35 AM
	Zacks Research Analysts Lift Earnings Estimates for GSK plc (NYSE:GSK) marketbeat.com - June 7 at 5:57 AM
	UPDATE 1-EU authorises GSK's RSV vaccine finance.yahoo.com - June 7 at 4:35 AM
	US FDA accepts GSK's licence application for cancer treatment Jemperli lse.co.uk - June 6 at 1:33 PM
	GSK granted FDA priority review for label expansion in cancer drug Jemperli msn.com - June 6 at 1:33 PM
	FDA Prioritizes GSK's Breakthrough Drug Jemperli for Endometrial Cancer Treatment, a First in Decades finance.yahoo.com - June 6 at 1:33 PM
	Franklin Resources Inc. Has $1.74 Million Stock Holdings in GSK plc (NYSE:GSK) marketbeat.com - June 6 at 5:48 AM
	GSK Gets FDA File Acceptance For Jemperli Endometrial Cancer Treatment marketwatch.com - June 6 at 3:32 AM
	GSK's Cancer Drug Jemperli Gets File Acceptance From US FDA money.usnews.com - June 6 at 3:32 AM
	Bank of America Corp DE Decreases Stock Position in GSK plc (NYSE:GSK) marketbeat.com - June 5 at 6:50 AM
	Victory Capital Management Inc. Invests $978,000 in GSK plc (NYSE:GSK) marketbeat.com - June 4 at 5:12 AM
	GSK plc (NYSE:GSK) Shares Sold by Renaissance Technologies LLC marketbeat.com - June 2 at 1:50 PM
	Down 12% since April, the GSK share price fall looks overdone to me uk.finance.yahoo.com - June 1 at 1:42 PM
	GSK CEO Emma Walmsley says A.I. could improve Big Pharma’s most ‘profound’ challenge: R&D productivity finance.yahoo.com - June 1 at 8:42 AM
	GSK Announces the COiMMUNITY Initiative to Help Achieve Higher Adult Vaccination Rates in the US finance.yahoo.com - June 1 at 8:42 AM
	US Approves Second RSV Vaccine barrons.com - May 31 at 10:41 PM
	GSK’s CEO says you need thick skin if you’re going to step into the C-suite fortune.com - May 31 at 5:40 PM
	Sei Investments Co. Raises Position in GSK plc (NYSE:GSK) marketbeat.com - May 29 at 7:37 AM
	GSK plc (NYSE:GSK) Stock Position Lowered by Kavar Capital Partners Group LLC marketbeat.com - May 26 at 1:59 PM
	Gucci-Owner Kering, Drugmaker GSK and Others Are Developing Global Targets on Nature Loss wsj.com - May 25 at 7:37 AM
	Gucci-Owner Kering, Drugmaker GSK and Others Are Developing a Global Standard on Nature Loss wsj.com - May 25 at 7:37 AM
	Market Digest: MKL, GSK, NFG finance.yahoo.com - May 24 at 8:40 AM
	Share tip: A spoonful of GSK will help your profit go up thetimes.co.uk - May 20 at 10:34 PM
	Scotia Capital Inc. Has $2.02 Million Stock Position in GSK plc (NYSE:GSK) marketbeat.com - May 19 at 7:59 AM
	GSK India reports Rs 133 crore net profit msn.com - May 17 at 1:09 PM
	Tempus Wealth Planning LLC Invests $679,000 in GSK plc (NYSE:GSK) marketbeat.com - May 17 at 10:39 AM
	Grabbing GSK For Buy Write Two Days Before It Trades Ex-Dividend forbes.com - May 16 at 5:06 PM
	BELLUS Health Inc. Calls Special Shareholders’ Meeting in Connection with GSK Acquisition finance.yahoo.com - May 16 at 5:06 PM
	Taika Capital LP Makes New Investment in GSK plc (NYSE:GSK) marketbeat.com - May 16 at 11:45 AM
	What To Expect From GSK In 2023 seekingalpha.com - May 16 at 1:29 AM
	GSK: So, just how big is the RSV opportunity? Up to $9bn, says one broker proactiveinvestors.com - May 15 at 1:31 PM
	If I’d invested £5k in GSK shares one year ago here’s what I’d have today msn.com - May 15 at 8:31 AM
	GSK hails court ruling on claim of Zantac cancer link thetimes.co.uk - May 12 at 8:04 PM
	GSK says Canadian court dismisses potential Zantac class suit msn.com - May 12 at 10:03 AM
	Brokerages Set GSK plc (NYSE:GSK) Price Target at $1,533.00 americanbankingnews.com - May 12 at 2:38 AM
	BRIEF-GSK Announces Intention To Sell Shares In Haleon msn.com - May 12 at 1:16 AM
	GSK To Sell Up To 2.5% Of Haleon's Shares markets.businessinsider.com - May 12 at 1:16 AM
	GSK to Sell $1 Billion Haleon Stake After Consumer Unit Spinoff bloomberg.com - May 11 at 3:15 PM
	GSK to sell 240 million shares in spin-off firm Haleon news.yahoo.com - May 11 at 3:15 PM
	GSK plc (NYSE:GSK) Shares Bought by Prime Capital Investment Advisors LLC marketbeat.com - May 11 at 6:50 AM
	FORA Capital LLC Reduces Holdings in GSK plc (NYSE:GSK) marketbeat.com - May 10 at 8:39 AM
	GSK plc (NYSE:GSK) Given Consensus Rating of "Hold" by Brokerages marketbeat.com - May 9 at 3:44 AM
	Roanoke Asset Management Corp NY Sells 2,800 Shares of GSK plc (NYSE:GSK) marketbeat.com - May 8 at 12:22 PM

Get GSK News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NYSE:GSK) was last updated on 6/8/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

GSK (GSK) News Today

GSK Media Mentions By Week

GSK Media Sentiment

GSK News Coverage

Related Companies and Tools

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info